Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement

Journal of the American College of Cardiology

Volumn 64, Issue 24, 2014, Pages 2605-2615

  Généreux, Philippe ^a,b,c   Cohen, David J ^d   Mack, Michael ^e   Rodes Cabau, Josep ^f   Yadav, Mayank ^b   Xu, Ke ^b   Parvataneni, Rupa ^b   Hahn, Rebecca ^a,b   Kodali, Susheel K ^a,b   Webb, John G ^g   Leon, Martin B ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e Baylor Healthcare System   (United States)

^f LAVAL UNIVERSITY   (Canada)

^g ST PAUL S HOSPITAL   (Canada)

Author keywords

aortic stenosis; bleeding; paravalvular leak; TAVR

Indexed keywords

ANEMIA; AORTA BALLOON; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; ARTICLE; BRAIN HEMORRHAGE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL (TOPIC); CREATININE CLEARANCE; ECHOCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART TAMPONADE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; INJURY; MORTALITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PREDICTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; UROGENITAL TRACT DISEASE; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; AORTIC VALVE STENOSIS; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMORRHAGE; KAPLAN MEIER METHOD; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VERY ELDERLY;

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLOPIDINE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ASPIRIN; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TICLOPIDINE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84917673051     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.08.052     Document Type: Article

References (42)

1. P. Genereux, S.J. Head, and N.M. Van Mieghem Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies J Am Coll Cardiol 59 2012 2317 2326
2. P. Genereux, D.J. Cohen, and M.R. Williams Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I trial (Placement of Aortic Transcatheter Valve) J Am Coll Cardiol 63 2014 1100 1109
3. J. Rodes-Cabau, H.L. Dauerman, and M.G. Cohen Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events J Am Coll Cardiol 62 2013 2349 2359
4. T. Pilgrim, S. Stortecky, F. Luterbacher, S. Windecker, and P. Wenaweser Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis J Thromb Thrombolysis 35 2013 456 462
5. R.J. Nuis, J. Rodes-Cabau, and J.M. Sinning Blood transfusion and the risk of acute kidney injury after transcatheter aortic valve implantation Circ Cardiovasc Interv 5 2012 680 688
6. B. Borz, E. Durand, and M. Godin Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis Heart 99 2013 860 865
7. P. Genereux, J.G. Webb, and L.G. Svensson Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of Aortic Transcatheter Valve) trial J Am Coll Cardiol 60 2012 1043 1052
8. D. Tchetche, R.M. Van der Boon, and N. Dumonteil Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-Rotterdam-Milano-Toulouse in Collaboration Plus (PRAGMATIC Plus) initiative Am Heart J 164 2012 402 409
9. K. Hayashida, T. Lefevre, and B. Chevalier Transfemoral aortic valve implantation new criteria to predict vascular complications J Am Coll Cardiol Intv 4 2011 851 858
10. E. Grube, G. Schuler, and L. Buellesfeld Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76
11. N. Piazza, E. Grube, and U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve Revalving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval Eurointervention 4 2008 242 249
12. J. Rodes-Cabau, J.G. Webb, and A. Cheung Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2010 1080 1090
13. M. Thomas, G. Schymik, and T. Walther Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 122 2010 62 69
14. M.B. Leon, C.R. Smith, and M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
15. C.R. Smith, M.B. Leon, and M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
16. N.E. Moat, P. Ludman, and M.A. de Belder Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry J Am Coll Cardiol 58 2011 2130 2138
17. M. Gilard, H. Eltchaninoff, and B. Iung Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
18. A. Linke, P. Wenaweser, and U. Gerckens Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-Centre ADVANCE Study Eur Heart J 35 2014 2672 2684
19. D.H. Adams, J.J. Popma, and M.J. Reardon Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
20. M.J. Mack, J.M. Brennan, and R. Brindis Outcomes following transcatheter aortic valve replacement in the United States JAMA 310 2013 2069 2077
21. E. Durand, D. Blanchard, and S. Chassaing Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation Am J Cardiol 113 2014 355 360
22. G.P. Ussia, M. Scarabelli, and M. Mule Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation Am J Cardiol 108 2011 1772 1776
23. M.B. Leon, N. Piazza, and E. Nikolsky Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
24. A.P. Kappetein, S.J. Head, and P. Genereux Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
25. P. Genereux, S. Kodali, and M.B. Leon Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation J Am Coll Cardiol Intv 4 2011 861 867
26. S. Toggweiler, R. Gurvitch, and J. Leipsic Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure J Am Coll Cardiol 59 2012 113 118
27. K. Hayashida, T. Lefevre, and B. Chevalier True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications J Am Coll Cardiol Intv 5 2012 207 214
28. A. Vincentelli, S. Susen, and T. Le Tourneau Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 349 2003 343 349
29. A. Casonato, S. Sponga, and E. Pontara Von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding Thromb Haemost 106 2011 58 66
30. N. Uriel, S.W. Pak, and U.P. Jorde Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
31. J.L. Blackshear, H.V. Schaff, S.R. Ommen, D. Chen, and W.L. Nichols Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy Mayo Clin Proc 86 2011 219 224
32. C. Godino, L. Lauretta, and A.G. Pavon Heyde's syndrome incidence and outcome in patients undergoing transcatheter aortic valve implantation J Am Coll Cardiol 61 2013 687 689
33. P. Genereux, S.J. Head, and R. Hahn Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature J Am Coll Cardiol 61 2013 1125 1136
34. G. Athappan, E. Patvardhan, and E.M. Tuzcu Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature J Am Coll Cardiol 61 2013 1585 1595
35. E. Van Belle, F. Juthier, and S. Susen Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry Circulation 129 2014 1415 1427
36. R.K. Binder, J.G. Webb, and A.B. Willson The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial J Am Coll Cardiol 62 2013 431 438
37. A.B. Willson, J.G. Webb, and T.M. Labounty 3-Dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis J Am Coll Cardiol 59 2012 1287 1294
38. M. Mok, M. Urena, and L. Nombela-Franco Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation J Thromb Thrombolysis 35 2013 450 455
39. I.J. Amat-Santos, J. Rodes-Cabau, and M. Urena Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation J Am Coll Cardiol 59 2012 178 188
40. R. Allende, J.G. Webb, and A.J. Munoz-Garcia Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients Eur Heart J 35 2014 2685 2696
41. S. Stortecky, L. Buellesfeld, and P. Wenaweser Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation Circ Cardiovasc Interv 6 2013 77 84
42. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747